Cymabay Therapeutics

1 Follower


CymaBay Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies to treat metabolic diseases, including serious rare and orphan diseases. The Company's product candidates include Arhalofenate, MBX...

Charles McWherter
SVP & Chief Scientific Officer
Dan Menold
Vice President, Finance
Klara Dickinson
Chief Regulatory and Quality Assurance Officer
Paul Quinlan
General Counsel and Secretary
Robert Martin
Senior Vice President, Manufacturing and Nonclinical Development
Becki Filice
SVP, Portfolio and Product Leadership
Lewis Stuart
Chief Commercial Officer
Dennis Kim
Chief Medical Officer

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.